Pivya U.S. branded launch to drag margins 100–150 bps
Alembic Pharmaceuticals Limited — Q4 FY26 Earnings Call (15 May 2026) 1. Overall Tone of Management: Neutral to Optimistic Management is broadly constructive on FY27 execution and growth (“confident of continuing this growth”, “targeting a low…
